Department of Anesthesiology
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is O  [Clear All Filters]
2000
Baba H, Goldstein PA, Okamoto M, Kohno T, Ataka T, Yoshimura M, Shimoji K.  2000.  Norepinephrine facilitates inhibitory transmission in substantia gelatinosa of adult rat spinal cord (part 2): effects on somatodendritic sites of GABAergic neurons.. Anesthesiology. 92(2):485-92.
1999
Lien CA, Belmont MR, Roth DLWray, Okamoto M, Abalos A, Savarese JJ.  1999.  Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery.. Anesthesiology. 91(1):119-26.
McAvoy T, Allen PB, Obaishi H, Nakanishi H, Takai Y, Greengard P, Nairn AC, Hemmings HC.  1999.  Regulation of neurabin I interaction with protein phosphatase 1 by phosphorylation.. Biochemistry. 38(39):12943-9.
1998
Baba H, Kohno T, Okamoto M, Goldstein PA, Shimoji K, Yoshimura M.  1998.  Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn.. J Physiol. 508 ( Pt 1):83-93.
1996
Kisor DF, Schmith VD, Wargin WA, Lien CA, Ornstein E, Cook DR.  1996.  Importance of the organ-independent elimination of cisatracurium.. Anesth Analg. 83(5):1065-71.
Ornstein E, Lien CA, Matteo RS, Ostapkovich ND, Diaz J, Wolf KB.  1996.  Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients.. Anesthesiology. 84(3):520-5.
Ornstein E, Lien CA, Matteo RS, Ostapkovich ND, Diaz J, Wolf KB.  1996.  Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients.. Anesthesiology. 84(3):520-5.
1995
Riker WF, Okamoto M, Artusio JF.  1995.  In vivo reversal of depolarizing neuromuscular blockade.. Arch Int Pharmacodyn Ther. 330(1):90-101.
Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K.  1995.  Thyroid hormone treatment after coronary-artery bypass surgery.. N Engl J Med. 333(23):1522-7.
1992
Harada K, Adams V, Okamoto M.  1992.  Effect of chronic pre- and post-natal low-dose ethanol exposure on brain enolase isoenzyme activities.. Brain Res. 580(1-2):334-7.
Okamoto M, Walewski JL, Artusio JF, Riker WF.  1992.  Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs.. Anesth Analg. 75(3):361-71.
1991
Lien CA, Matteo RS, Ornstein E, Schwartz AE, Diaz J.  1991.  Distribution, elimination, and action of vecuronium in the elderly.. Anesth Analg. 73(1):39-42.
1990
Riker WF, Okamoto M, Artusio JF.  1990.  The interactions of ouabain with post-tetanic and facilitatory drug potentiations at cat soleus neuromuscular junctions in vivo.. Neurochem Res. 15(4):457-65.
1989
Ouimet CC, Hemmings HC, Greengard P.  1989.  ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Immunocytochemical localization in rat brain.. J Neurosci. 9(3):865-75.
1988
Hökfelt T, Foster G, Schultzberg M, Meister B, Schalling M, Goldstein M, Hemmings HC, Ouimet C, Greengard P.  1988.  DARPP-32 as a marker for D-1 dopaminoceptive cells in the rat brain: prenatal development and presence in glial elements (tanycytes) in the basal hypothalamus.. Adv Exp Med Biol. 235:65-82.
Ouimet CC, Hemmings HC, Greengard P.  1988.  Dopamine-regulated protein phosphorylation in the basal ganglia.. Adv Exp Med Biol. 235:1-17.
Agnati LF, Fuxe K, Zoli M, Ferraguti F, Benfenati F, Ouimet CC, Walaas SI, Hemmings HC, Goldstein M, Greengard P.  1988.  Morphometrical evidence for a complex organization of tyrosine hydroxylase-, enkephalin- and DARPP-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum.. Neuroscience. 27(3):785-97.
Foster GA, Schultzberg M, Kökfelt T, Goldstein M, Hemmings HC, Ouimet CC, Walaas SI, Greengard P.  1988.  Ontogeny of the dopamine and cyclic adenosine-3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the pre- and postnatal mouse central nervous system.. Int J Dev Neurosci. 6(4):367-86.
1987
Foster GA, Schultzberg M, Hökfelt T, Goldstein M, Hemmings HC, Ouimet CC, Walaas SI, Greengard P.  1987.  Development of a dopamine- and cyclic adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation.. J Neurosci. 7(7):1994-2018.
1986
Stone RA, Laties AM, Hemmings HC, Ouimet CC, Greengard P.  1986.  DARPP-32 in the ciliary epithelium of the eye: a neurotransmitter-regulated phosphoprotein of brain localizes to secretory cells.. J Histochem Cytochem. 34(11):1465-8.
1984
Ouimet CC, Miller PE, Hemmings HC, Walaas SI, Greengard P.  1984.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.. J Neurosci. 4(1):111-24.
1969
Orti E, Neuwirth J, Scharoun J.  1969.  Red fluorescence of C19 and C21 steroids.. Anal Biochem. 32(3):381-5.